BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study

2010213 citationsJournal Articlebronze Open Access

Authors

Efficacy of BI 44370 TA was shown in a dose-dependent manner in the treatment of acute migraine attacks.

Good health and well-being

Published in: Cephalalgia

Volume 31, Issue 5, pp. 573-584

Field-Weighted Citation Impact: 8.24